CRSP Today - Jul 16: Six Red Days in a Row

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

CRSP Today - Jul 16: Six Red Days in a Row

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your go-to guy for breaking down the stock scene. I’ve been in the investing game for years, and today we’re checking out CRISPR Therapeutics, or CRSP. Not a great day for them — the stock got smoked, down over 5%. Ouch.

So, what happened? It’s been a rough stretch lately, and today marked six straight red days for CRSP. That’s a total drop of about 18% over this little losing streak. A lot of folks are feeling the pressure and hitting that sell button fast. Volume was pretty low today too, which usually means people are a bit hesitant to jump in right now.

Now, why’s this happening? Well, the chatter around the stock is a mix of uncertainty and some folks questioning its fair value. There's a report floating around suggesting CRISPR has about $2.4 billion in cash, which sounds solid, but it hasn’t really helped the stock price. Investors are likely worried about the overall market and the competition heating up in the CRISPR space. Plus, there’s been some buzz about Intellia Therapeutics, which has a hefty short interest. That might be pulling some eyes away from CRISPR and causing a bit of a standoff in the market.

And just to keep you in the loop, there’s talk about CRISPR needing to show some solid progress soon to win back investor confidence. They’ve got to prove they can deliver results to turn this ship around.

So, yeah, it’s been a tough time for CRISPR. If you’re watching this stock, just keep your eyes peeled. Remember, this is just info and entertainment, not financial advice. Thanks for hanging out with me today! Catch you later!

まだレビューはありません